Search clinical trials for: Aromasin

Total 291 results

Biogen

Completed

Hormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule Finding

Breast Cancer

United States, Russian Federation, Australia, Belgium
Pfizer

Terminated

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

Early Breast Cancer
Pfizer

Completed

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST) (FAST)

Post Menopausal Women With Early Breast Cancer
Novosibirsk City Hospital #2
Siberian Branch of the Russian Academy of Medical Sciences

Completed

Molecular, Cytological Features and Genetic Susceptibility of COPD Attributable to Different Environmental Exposures 2

Chronic Obstructive Pulmonary Disease

Russian Federation
Actavis Inc.

Withdrawn

Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects

Healthy

South Africa
Complexo Hospitalario Universitario de A Coruña

Completed

Acceptance of Different Thickeners in Dysphagia

Dysphagia | Dysphagia, Oropharyngeal

Spain
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Determining Total Aromatic Amino Acid Requirements in Pregnant Women

Pregnancy Related

Canada
Novosibirsk City Hospital #2
Siberian Branch of the Russian Academy of Medical Sciences

Completed

Molecular, Cytological Features and Genetic Susceptibility of COPD Attributable to Different Environmental Exposures

Chronic Obstructive Pulmonary Disease

Russian Federation
Pfizer

Completed

Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane (TEAM)

Breast Neoplasms

United States
HaEmek Medical Center, Israel

Completed

Treatment of Acute Tracheitis and Laryngitis With Essential Oils of Aromatic Plants

Viral Laryngitis | Viral Tracheitis

Israel
HaEmek Medical Center, Israel

Completed

Treatment of Acute Pharyngo-Tonsillitis With Essential Oils of Aromatic Plants

Viral Pharyngitis | Viral Tonsillitis

Israel
HaEmek Medical Center, Israel

Completed

Treatment of Acute Rhino-Sinusitis With Essential Oils of Aromatic Plants

Rhino-Sinusitis

Israel
Pfizer

Completed

Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen

Breast Neoplasms

Belgium, Brazil, United States, India, Peru, Philippines, Mexico, Canada, Colombia
Pfizer

Completed

Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer

Metastatic Breast Cancer

China
Masonic Cancer Center, University of Minnesota

Completed

Exemestane in Post-Menopausal Women With NSCLC

Non-Small Cell Lung Cancer

United States
Roxane Laboratories

Completed

Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Breast Cancer

United States
Pfizer

Completed

Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China

Breast Neoplasms

China
Second Affiliated Hospital of Guangzhou Medical...
First Affiliated Hospital, Sun Yat-Sen University; West China Hospital; Guangzhou... and other collaborators

Unknown

HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions

Epilepsy | Neuropathy | Blepharospasm | Psychiatric Illness

China
Pfizer

Completed

Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin

Breast Neoplasms
McGill University Health Centre/Research Institute...
The Louise And Alan Edwards Foundation

Completed

Chronic Widespread Pain and White Blood Cell Activation

Widespread Chronic Pain

Canada
National University Hospital, Singapore

Unknown

Prospective Study of UDP-gluconoryltransferase 2B17 Genotype as a Predictive Marker of Exemestane PK and PD

Breast Carcinoma

Singapore
Roxane Laboratories

Completed

Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions

Breast Cancer

United States
Roxane Laboratories

Completed

Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions

Breast Cancer

United States
Pfizer

Terminated

An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin

Breast Neoplasms

India
Nordic Society of Gynaecological Oncology - Clinical...

Completed

Exemestane in Advanced and Recurrent Endometrial Carcinoma

Endometrial Cancer

Norway
Georgetown University
Novartis Pharmaceuticals

Terminated

Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer

Breast Cancer

United States
Pfizer

Terminated

A Survey Of Clinical Practice Of Adjuvant Treatment Of Breast Cancer Using Exemestane (Aromasin®) In Postmenopausal Hr+ Patients (ETAPE)

Breast Cancer
Pfizer

Completed

Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients

Breast Neoplasms

France
Ivan FN Hung MD
Pamela Youde Nethersole Eastern Hospital

Recruiting

Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction

Coronavirus Disease 2019

Hong Kong
Pfizer

Terminated

A Non-Interventional Study With Aromasin® As Adjuvant Treatment Of Invasive Early Breast Cancer

Invasive Early Breast Cancer

Romania
Hellenic Breast Surgeons Society

Terminated

Adjuvant Post-Tamoxifen Exemestane Trial (ATENA)

Breast Cancer

Greece
Pfizer

Terminated

Aromasin® As Adjuvant Treatment In Postmenopausal Women With Invasive, Estrogen Receptor Positive Early Breast Cancer

Breast Neoplasms

Serbia, Croatia, Estonia
Cukurova University

Completed

Effects of Aromatic Solution Applied After Surgery

Surgery | Nurse's Role | Thirst | Nausea and Vomiting, Postoperative | Throat, Sore

Turkey
Krzysztof Bankiewicz
National Institute of Neurological Disorders and Stroke (NINDS); University...

Recruiting

A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients (AADC)

AADC Deficiency

United States
Pfizer

Completed

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

Breast Cancer

Korea, Republic of
Pfizer
Astellas Pharma Inc; Medivation, Inc.

Active, not recruiting

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Breast Cancer

United States, Spain, Belgium, Canada, Italy, Ireland, United Kingdom
Chipscreen Biosciences, Ltd.

Completed

Trial of Chidamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Breast Cancer

China
Organisation for Oncology and Translational Research

Unknown

Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer

Hormone Receptor Positive Malignant Neoplasm of Breast

China
Ohio State University Comprehensive Cancer Center
Pfizer

Completed

Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer

Breast Cancer

United States
Merck Sharp & Dohme LLC

Completed

A Phase II Trial of Ridaforolimus and Exemestane, Compared to Ridaforolimus, Dalotuzumab and Exemestane in Participants With Breast Cancer (MK-8669-064)

Breast Neoplasms
Merrimack Pharmaceuticals

Completed

Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer

Her2 Negative Breast Cancer Patients

United States, Spain, Canada, Germany, Russian Federation
University of Michigan Rogel Cancer Center
Damon Runyon Cancer Research Foundation

Completed

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

Pain | Breast Cancer | Arthralgia

United States
Syndax Pharmaceuticals

Completed

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer (ENCORE301)

Breast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-Positive

United States, Czechia, Canada, Hungary, Russian Federation
First Affiliated Hospital of Zhejiang University

Recruiting

Dalpiciclib in Combination With Exemestane and Trastuzumab Plus Pyrotinib in Early Triple Positive Breast Cancer

Breast Cancer | HER2-positive Breast Cancer | Estrogen Receptor Positive Tumor

China
National Cancer Institute (NCI)

Active, not recruiting

Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer

Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | Atypical Hyperplasia

United States
M.D. Anderson Cancer Center
Susan G. Komen Breast Cancer Foundation

Terminated

Exemestane-RAD001-Metformin

Breast Cancer

United States
AstraZeneca

Completed

The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer (EFECT)

Metastatic Breast Cancer | Locally Advanced Breast Cancer

Sweden, United States, Russian Federation, South Africa, United Kingdom, Germany, Hungary, Canada, Belgium, Denmark, Israel, Argentina, France, Brazil, Spain
Syndax Pharmaceuticals

Completed

Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

Breast Cancer | Estrogen Receptor Positive Breast Cancer

United States
Gilead Sciences

Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

Solid Tumors and Lymphomas

United States
Gilead Sciences

Terminated

GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer

Advanced Estrogen Receptor Positive HER2- Breast Cancer

United States

Search clinical trials for: Aromasin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations